Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 May 2019 | Story Xolisa Mnukwa
UFS Debate Society
The UFS Debate Society led by example at the 2019 Jozi Rumble.

After competing in the Jozi Rumble final for six consecutive years, the UFS Debate Society won the competition – Africa’s largest intercollegiate debate open – for the second consecutive year. The tournament took place at the University of the Witwatersrand (Wits) in April 2019.

After seven preliminary rounds, three UFS teams out of a total of 100 competing teams overall were placed in the top 16, earning them a place in the quarterfinals – where they faced each other. A composite team of UFS LLB graduate and LLM student, Lehakoe Masedi, and a partner from Wits beat all teams, qualified for the final themed ‘This house regrets the glorification of opulence in popular culture’, and won the league.

“It was one of the most validating moments of my entire debating career; everybody wants to win the Jozi Rumble, and to have done it and to be the best speaker is truly amazing,” said Lehakoe. The top-ranking speaker at the tournament added that she had been working hard, and that she is glad that her efforts are coming full circle.

The UFS sent six teams overall to the tournament, including two novice teams competing in their first-ever intercollegiate debate tournament. 

“Speaking at the Jozi Rumble debate tournament for the first time was truly an educational experience; it exposed me to the dynamics of varsity-level debating,” said Simphiwe Yana, debater in of the UFS novice teams.

The UFS speaking squad consisted of Lehakoe Masedi, 2018 Abe Bailey Bursary victor and Rhodes scholarship recipient Nkahiseng Ralepeli, Khotso Khokho, Siyanda Rixana, Morena Moabi, Simphiwe Yana, Luvuyo Shoco, Asemahle Noholoza, and Nontobeko Msimangu. Former Chairperson of the UFS Debate Society and Editor-in-Chief of the IRAWA newspaper, Tshiamo Malatji, was also present at the tournament as the Tabulation Director. 

On 11 May 2019, the UFS will travel to the University of Pretoria to defend yet another debate open title at the Pretoria Parlay Intervarsity. 


News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept